103 related articles for article (PubMed ID: 32001660)
1. Levels of anxiety and distress following receipt of positive screening tests in Australia's HPV-based cervical screening programme: a cross-sectional survey.
Dodd RH; Mac O; Brotherton JML; Cvejic E; McCaffery KJ
Sex Transm Infect; 2020 May; 96(3):166-172. PubMed ID: 32001660
[TBL] [Abstract][Full Text] [Related]
2. Psychosocial impact of testing human papillomavirus positive in Australia's human papillomavirus-based cervical screening program: A cross-sectional survey.
Chadwick V; Bennett KF; McCaffery KJ; Brotherton JML; Dodd RH
Psychooncology; 2022 Jul; 31(7):1110-1119. PubMed ID: 35128756
[TBL] [Abstract][Full Text] [Related]
3. Anxiety and distress following receipt of results from routine HPV primary testing in cervical screening: The psychological impact of primary screening (PIPS) study.
McBride E; Marlow LAV; Forster AS; Ridout D; Kitchener H; Patnick J; Waller J
Int J Cancer; 2020 Apr; 146(8):2113-2121. PubMed ID: 31251820
[TBL] [Abstract][Full Text] [Related]
4. Testing positive for human papillomavirus in routine cervical screening: examination of psychosocial impact.
McCaffery K; Waller J; Forrest S; Cadman L; Szarewski A; Wardle J
BJOG; 2004 Dec; 111(12):1437-43. PubMed ID: 15663132
[TBL] [Abstract][Full Text] [Related]
5. Psychological burden of testing positive for high-risk human papillomavirus on women with atypical cervical cytology: a prospective study.
Kwan TT; Cheung AN; Lo SS; Lee PW; Tam KF; Chan KK; Ngan HY
Acta Obstet Gynecol Scand; 2011 May; 90(5):445-51. PubMed ID: 21306349
[TBL] [Abstract][Full Text] [Related]
6. Socio-economic variations in anticipated adverse reactions to testing HPV positive: Implications for the introduction of primary HPV-based cervical screening.
O'Connor M; O'Leary E; Waller J; Gallagher P; Martin CM; O'Leary JJ; Sharp L;
Prev Med; 2018 Oct; 115():90-96. PubMed ID: 30144488
[TBL] [Abstract][Full Text] [Related]
7. Psychological Impact of Primary Screening (PIPS) for HPV: a protocol for a cross-sectional evaluation within the NHS cervical screening programme.
McBride E; Marlow L; Forster AS; Moss S; Myles J; Kitchener H; Patnick J; Waller J
BMJ Open; 2016 Dec; 6(12):e014356. PubMed ID: 28011816
[TBL] [Abstract][Full Text] [Related]
8. Psychological impact of human papillomavirus testing in women with borderline or mildly dyskaryotic cervical smear test results: cross sectional questionnaire study.
Maissi E; Marteau TM; Hankins M; Moss S; Legood R; Gray A
BMJ; 2004 May; 328(7451):1293. PubMed ID: 15166066
[TBL] [Abstract][Full Text] [Related]
9. Social and psychological impact of HPV testing in cervical screening: a qualitative study.
McCaffery K; Waller J; Nazroo J; Wardle J
Sex Transm Infect; 2006 Apr; 82(2):169-74. PubMed ID: 16581749
[TBL] [Abstract][Full Text] [Related]
10. Primary HPV testing versus cytology-based cervical screening in women in Australia vaccinated for HPV and unvaccinated: effectiveness and economic assessment for the National Cervical Screening Program.
Lew JB; Simms KT; Smith MA; Hall M; Kang YJ; Xu XM; Caruana M; Velentzis LS; Bessell T; Saville M; Hammond I; Canfell K
Lancet Public Health; 2017 Feb; 2(2):e96-e107. PubMed ID: 29253402
[TBL] [Abstract][Full Text] [Related]
11. Implementation of Australia's renewed cervical screening program: Preparedness of general practitioners and nurses.
Sultana F; Roeske L; Malloy MJ; McDermott TL; Saville M; Brotherton JML
PLoS One; 2020; 15(1):e0228042. PubMed ID: 31995585
[TBL] [Abstract][Full Text] [Related]
12. Women's experiences of the renewed National Cervical Screening Program in Australia 12 months following implementation: a qualitative study.
Dodd RH; Mac OA; McCaffery KJ
BMJ Open; 2020 Jul; 10(7):e039041. PubMed ID: 32665351
[TBL] [Abstract][Full Text] [Related]
13. Assessing the role of education in women's knowledge and acceptance of adjunct high-risk human Papillomavirus testing for cervical cancer screening.
Papa D; Moore Simas TA; Reynolds M; Melnitsky H
J Low Genit Tract Dis; 2009 Apr; 13(2):66-71. PubMed ID: 19387125
[TBL] [Abstract][Full Text] [Related]
14. Patterns of anxiety and distress over 12 months following participation in HPV primary screening.
Marlow LAV; McBride E; Ridout D; Forster AS; Kitchener H; Waller J
Sex Transm Infect; 2022 Jun; 98(4):255-261. PubMed ID: 34344834
[TBL] [Abstract][Full Text] [Related]
15. Routine cervical screening by primary HPV testing: early findings in the renewed National Cervical Screening Program.
Machalek DA; Roberts JM; Garland SM; Thurloe J; Richards A; Chambers I; Sivertsen T; Farnsworth A
Med J Aust; 2019 Aug; 211(3):113-119. PubMed ID: 31168828
[TBL] [Abstract][Full Text] [Related]
16. The projected timeframe until cervical cancer elimination in Australia: a modelling study.
Hall MT; Simms KT; Lew JB; Smith MA; Brotherton JM; Saville M; Frazer IH; Canfell K
Lancet Public Health; 2019 Jan; 4(1):e19-e27. PubMed ID: 30291040
[TBL] [Abstract][Full Text] [Related]
17. "Knowing that I had HPV, I literally just shut down": A qualitative exploration of the psychosocial impact of human papillomavirus (HPV) in women living with mental health conditions.
O'Donnell N; Waller J; Marlow L; Anderson NC; McBride E
Br J Health Psychol; 2024 Feb; 29(1):80-94. PubMed ID: 37658582
[TBL] [Abstract][Full Text] [Related]
18. Decline in prevalence of human papillomavirus infection following vaccination among Australian Indigenous women, a population at higher risk of cervical cancer: The VIP-I study.
McGregor S; Saulo D; Brotherton JML; Liu B; Phillips S; Skinner SR; Luey M; Oliver L; Stewart M; Tabrizi SN; Garland S; Kaldor JM
Vaccine; 2018 Jul; 36(29):4311-4316. PubMed ID: 29880245
[TBL] [Abstract][Full Text] [Related]
19. Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries.
Cuzick J; Arbyn M; Sankaranarayanan R; Tsu V; Ronco G; Mayrand MH; Dillner J; Meijer CJ
Vaccine; 2008 Aug; 26 Suppl 10():K29-41. PubMed ID: 18847555
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
